Microorganism Enterobacteriaceae 570 94.0 98.4 Bacillus 155 75.5 93.5 CoNS 120 46.7 90.8 Staphylococcus aureus 81 96.3 100.0 Streptococci 78 87.2 97.4 Anaerobes 56 28.6 60.7 Pseudomonas 43 93.0 97.7 Other Gram negative 36 55.6 88.9 Enterococci 27 92.6 100.0 Other Gram positive 22 27.3 77.3 Yeast 22 18.2 68.2 Acinetobacter 11 81.8 81.8 All isolates 1221 79.9 94.0 MDRO Yes 192 92.2 97.9 No 1029 7...

Delamanid, recently available for the treatment of multidrug-resistant tuberculosis (MDR TB), has had limited use outside clinical trials. We present the early treatment results for 53 patients from 7 countries who received a delamanid-containing treatment for MDR TB. Results show good tolerability and treatment response at 6 months.

Poultry Environment and farm Practices Influencing the Isolation rate of Multi-Drug Resistant Salmonella from water feed in Zaria, NigeriaMUSA, I.W., MANSUR, M.S., SA’IDU, L., MOHAMMED B, ALIYU, H.B

In 2008, diagnosis and investigation of 2 multidrug-resistant tuberculosis cases with matching genotypes led to identification of an outbreak among foreign-born persons who performed short-term seafood production work in Alaska during 2006. Tuberculosis control programs should consider the possibility of domestic transmission even among foreign-born patients.

INTRODUCTION The World Health Organization recommends essential measures to "combat drug resistance", including instituting surveillance "everywhere". Standardized metrics are crucial for reliable surveillance. Studies publish metrics with varying definitions for multi-drug resistant organisms (MDRO). The Society for Healthcare Epidemiology of America (SHEA) and the Healthcare Infection Control...

Treatment of multidrug-resistant (MDR) tuberculosis (TB) (defined as resistance to at least isoniazid and rifampicin, two core first-line drugs for TB treatment) and extensively drug-resistant (XDR)-TB (defined as resistance to isoniazid and rifampicin plus any fluoroquinolone and at least one of the injectable drugs amikacin, capreomycin or kanamycin) are a challenge for both clinicians and pu...

Abstract Logistic regression and neural networks have developed rapidly in recent years, the poor diet of people modern society has led to emergence various diseases which drug-resistant bacterial infections occur during treatment, so this paper proposes logistic analyze risk factors preventive control multi-drug-resistant infections. A model was established determine magnitude effect each fact...

Objectives: The aim of this study was to evaluate the procalcitonin (PCT) changes in two different high-dose colistin regimens in the treatment of multi-drug resistant MDR gram negative infections in ICU patients. Method: This is a prospective study of adult ICU patients with bacteremia and ventilator associated pneumonia (VAP) caused by MDR gram negative pathogens. Patients were assigned to t...

BACKGROUND One-fifth of the patients on multidrug-resistant tuberculosis treatment at the Drug-Resistant-TB (DR-TB) Site in Gujarat are lost-to-follow-up(LFU). OBJECTIVE To understand patients' and providers' perspectives on reasons for LFU and their suggestions to improve retention-in-care. DESIGN Qualitative study conducted between December 2013-March 2014, including in-depth interviews w...

BACKGROUND The rapid emergence and spread of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) has raised considerable public health concern in both developed and developing countries. The current study aimed to address the extent of this phenomenon in healthy preschool children of a developing country. MATERIALS AND METHODS We conducted a prospective study from April...